| Ontology | CARD's Antibiotic Resistance Ontology |
| Accession | ARO:3005175 |
| Synonym(s) | 4-thioureido-iminomethylpyridinium perchlorate |
| Definition | Perchlozone is a novel thiosemicarbazone used for the treatment of multidrug-resistant tuberculosis. It is similar to thiacetazone with only a different side chain attached to the thiosemicarbazone moiety. Perchlozone is a prodrug that is activated by ethA and inhibits the HadABC complex. |
| SMILES | N/A |
| PubChem | 5374694 |
| Drug Class | thiosemicarbazone antibiotic |
| Classification | 2 ontology terms | Show |
| Parent Term(s) | 1 ontology terms | Show + thiosemicarbazone antibiotic [Drug Class] |
| Sub-Term(s) | 1 ontology terms | Show + Mycobacterium tuberculosis ethA mutations conferring resistance to perchlozone confers_resistance_to_antibiotic |
| Publications | Mokrousov I, et al. 2020. Antibiotics (Basel) 9(10): Genetic Variation Putatively Associated with Mycobacterium tuberculosis Resistance to Perchlozone, a New Thiosemicarbazone: Clues from Whole Genome Sequencing and Implications for Treatment of Multidrug-Resistant Tuberculosis. (PMID 33022959) Gopal P, et al. 2015. Int J Antimicrob Agents 45(4):430-3 The new tuberculosis drug Perchlozone® shows cross-resistance with thiacetazone. (PMID 25704063) |
| Curator | Description | Most Recent Edit |
|---|